/A
Active, not recruiting
- Conditions
- Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
- Registration Number
- EUCTR2011-002773-39-SE
- Lead Sponsor
- niversitetssjukhuset Örebro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie cardiovascular disease interventions in the 2011 Örebro University Hospital trial?
How does the trial's approach compare to standard-of-care treatments for specific cardiovascular disease subtypes?
What biomarkers are associated with patient response in cardiovascular disease trials at Örebro University Hospital?
What adverse events are reported in early-phase cardiovascular disease trials at Örebro University Hospital?
What combination therapies or competitor drugs are being studied for cardiovascular disease in Sweden?